Voigt E - Search Results

1

Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort.

Vogel M, Voigt E, Schäfer N, Goldmann G, Schwarz N, Kalff JC, Sauerbruch T, Wolff M, Rockstroh JK, Spengler U. Vogel M, et al. Among authors: voigt e. Liver Transpl. 2005 Dec;11(12):1515-21. doi: 10.1002/lt.20498. Liver Transpl. 2005. PMID: 16315295 Free article.

2

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.

Vogel M, Voigt E, Michaelis HC, Sudhop T, Wolff M, Türler A, Sauerbruch T, Rockstroh JK, Spengler U. Vogel M, et al. Among authors: voigt e. Liver Transpl. 2004 Jul;10(7):939-44. doi: 10.1002/lt.20165. Liver Transpl. 2004. PMID: 15237382 Free article.

3

Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort.

Wojcik K, Vogel M, Voigt E, Speidel N, Kalff JC, Goldmann G, Oldenburg J, Sauerbruch T, Rockstroh JK, Spengler U. Wojcik K, et al. Among authors: voigt e. AIDS. 2007 Jun 19;21(10):1363-5. doi: 10.1097/QAD.0b013e3280d5a79a. AIDS. 2007. PMID: 17545715

4

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals.

Vogel M, Bertram N, Wasmuth JC, Wyen C, Voigt E, Schwarze-Zander C, Sudhop T, Fätkenheuer G, Rockstroh JK, Reichel C. Vogel M, et al. Among authors: voigt e. J Antimicrob Chemother. 2009 May;63(5):988-91. doi: 10.1093/jac/dkp044. Epub 2009 Mar 6. J Antimicrob Chemother. 2009. PMID: 19270314

5

An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.

Kokordelis P, Krämer B, Körner C, Boesecke C, Voigt E, Ingiliz P, Glässner A, Eisenhardt M, Wolter F, Kaczmarek D, Nischalke HD, Rockstroh JK, Spengler U, Nattermann J. Kokordelis P, et al. Among authors: voigt e. Hepatology. 2014 Mar;59(3):814-27. doi: 10.1002/hep.26782. Epub 2014 Jan 21. Hepatology. 2014. PMID: 24382664

6

Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.

Wasmuth JC, Herhaus C, Römer K, Salzberger B, Kaiser R, Schliefer K, Voigt E, Rockstroh JK. Wasmuth JC, et al. Among authors: voigt e. AIDS. 2002 May 3;16(7):1077-8. doi: 10.1097/00002030-200205030-00018. AIDS. 2002. PMID: 11953478 No abstract available.

7

Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C.

Krämer B, Nischalke HD, Boesecke C, Ingiliz P, Voigt E, Mauss S, Stellbrink HJ, Baumgarten A, Rockstroh JK, Spengler U, Nattermann J. Krämer B, et al. Among authors: voigt e. AIDS. 2013 Nov 13;27(17):2817-9. doi: 10.1097/01.aids.0000433234.78807.54. AIDS. 2013. PMID: 23939236

8

CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.

Kokordelis P, Krämer B, Boesecke C, Voigt E, Ingiliz P, Glässner A, Wolter F, Srassburg CP, Spengler U, Rockstroh JK, Nattermann J. Kokordelis P, et al. Among authors: voigt e. J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):338-46. doi: 10.1097/QAI.0000000000000793. J Acquir Immune Defic Syndr. 2015. PMID: 26509931

9

Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.

Boesecke C, Ingiliz P, Reiberger T, Stellbrink HJ, Bhagani S, Page E, Mauss S, Lutz T, Voigt E, Guiguet M, Valantin MA, Baumgarten A, Nelson M, Vogel M, Rockstroh JK; NEAT Study Group. Boesecke C, et al. Among authors: voigt e. Infection. 2016 Feb;44(1):93-101. doi: 10.1007/s15010-015-0856-9. Infection. 2016. PMID: 26481253

10

Pegylated interferon alpha-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients.

Voigt E, Schulz C, Klausen G, Goelz J, Mauss S, Schmutz G, Jessen H, Weitner L, Mutz A, Schranz D, Rockstroh JK; Kaad Study Group. Voigt E, et al. J Infect. 2006 Jul;53(1):36-42. doi: 10.1016/j.jinf.2005.09.007. Epub 2005 Nov 2. J Infect. 2006. PMID: 16269184 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page